Haggerston BioHealth gives subscribers exclusive access to investment-bank grade biotech and health research. This premium service also provides watch lists, alerts, and analysis of more than 1,000 stocks, so you are informed about the hottest new developments, likely gainers and fallers, plus any other breaking news. Haggerston BioHealth aims to discover and highlight the best possible investment opportunities, and to help you make money by investing in the pharma, healthcare, and biotech industries.
At the beginning of every week, you will receive 4-5 stock tips that have been generated using a combination of algorithmic techniques, financial modeling, and forecasting, share price performance, and detailed market and competitor analysis.
There are over 80 recommendations to explore with more being added every week.
Ingham maps out clinical trial schedules, compares companies, breaks down market share, forecasts headwinds and tailwinds, and creates valuation tools. Every investment he recommends is backed up by hard data, which is only available to subscribers.